VRXANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as VRXAW
Veraxa Biotech AG - Post de-SPAC
Last filing: 20-F on Jun 16, 2026
$1.00−0.11 (-9.91%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
9 of Veraxa Biotech AG - Post de-SPAC's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 6-K | Oct 15, 2026 | Oct 15, 2026 | SEC EDGAR |
| Current report | 6-K | Sep 4, 2026 | Sep 4, 2026 | SEC EDGAR |
| Current report | 6-K | Aug 24, 2026 | Aug 24, 2026 | SEC EDGAR |
| Current report | 6-K | Jul 31, 2026 | Jul 31, 2026 | SEC EDGAR |
| Current report | 6-K | Jul 27, 2026 | Jul 27, 2026 | SEC EDGAR |
| Current report | 6-K | Jul 27, 2026 | Jul 27, 2026 | SEC EDGAR |
| Current report | 6-K | Jun 18, 2026 | Jun 18, 2026 | SEC EDGAR |
| Annual report | 20-F | Dec 31, 2025 | Jun 16, 2026 | SEC EDGAR |
| Current report | 6-K | Jun 10, 2026 | Jun 11, 2026 | SEC EDGAR |